Demographic trends of patients undergoing ophthalmic surgery in Ontario, Canada: a population-based study.


Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
05 2023
Historique:
received: 28 01 2023
accepted: 18 05 2023
medline: 7 6 2023
pubmed: 6 6 2023
entrez: 6 6 2023
Statut: ppublish

Résumé

In this study, we investigated the demographic trends of patients undergoing ophthalmic surgeries based on geographic region, priority level, and sex. This population-based retrospective cohort study used the Ontario Health Wait Times Information System (WTIS) database from 2010 to 2021. The WTIS contains non-emergent surgical case volume and wait time data for 14 different regions, three priority levels (high, medium and low) and six ophthalmic subspecialty procedures. Over the study period, on average 83 783 women and 65 555 men underwent ophthalmic surgery annually in Ontario. Overall, women waited an aggregate mean of 4.9 days longer than men to undergo surgery, and this disparity persisted across all geographic and priority stratifications. The average age at the time of surgery has been increasing slowly at a rate of 0.02 years/year (95% CI 0.00 to 0.05), with women being 0.6 years older than men overall. These findings indicate that women have consistently longer wait times than men. The results of this study may be a sign of systemic sex-based differences that could be affecting women who need to be further explored for health equity.

Identifiants

pubmed: 37278413
pii: bmjophth-2023-001253
doi: 10.1136/bmjophth-2023-001253
pmc: PMC10230992
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Acta Ophthalmol. 2014 Aug;92(5):432-8
pubmed: 23981482
Can J Public Health. 2005 Mar-Apr;96 Suppl 2:S78-96
pubmed: 16078557
J Cataract Refract Surg. 2012 Jun;38(6):1086-93
pubmed: 22541829
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Health Policy. 2006 Dec;79(2-3):132-43
pubmed: 16519957
BMC Musculoskelet Disord. 2016 Sep 21;17(1):401
pubmed: 27653159
BMC Health Serv Res. 2022 Apr 29;22(1):579
pubmed: 35488331
Can J Ophthalmol. 2022 Jul 1;:
pubmed: 35780860
Can J Ophthalmol. 2016 Jun;51(3):142-6
pubmed: 27316258
JAMA Surg. 2022 Jul 1;157(7):609-616
pubmed: 35583876
Ophthalmology. 2014 Apr;121(4):946-51
pubmed: 24411577
Healthc Q. 2009;12 Spec No Ontario:1
pubmed: 19458501
Ophthalmology. 2022 Jan;129(1):111-113
pubmed: 34271073
J Surg Oncol. 2021 Jan;123(1):236-244
pubmed: 33084065
Clin Ophthalmol. 2023 Jun 26;17:1823-1831
pubmed: 37397955
CMAJ. 2007 Apr 24;176(9):1285-90
pubmed: 17452662
BMJ Open Ophthalmol. 2022 Feb 4;7(1):e000937
pubmed: 35141421
J Am Coll Surg. 2021 Aug;233(2):316-319
pubmed: 33964401
Ophthalmology. 2007 Sep;114(9):1670-8
pubmed: 17383730
Can J Ophthalmol. 2023 Jun;58(3):e104-e106
pubmed: 36356651
Healthc Policy. 2012 Aug;8(1):80-91
pubmed: 23968605
Int J Equity Health. 2016 Jan 19;15:10
pubmed: 26786522
Clin Ophthalmol. 2013;7:1655-60
pubmed: 23986630
Am J Ophthalmol. 2020 Nov;219:284-294
pubmed: 32640255
CMAJ. 2021 Oct 18;193(41):E1584-E1591
pubmed: 34663601
Sci Rep. 2021 Oct 18;11(1):20611
pubmed: 34663850
Obes Surg. 2020 Mar;30(3):961-968
pubmed: 31705416
Ophthalmic Epidemiol. 2005 Apr;12(2):91-101
pubmed: 16019692
Optom Vis Sci. 2011 Jan;88(1):155-63
pubmed: 21076360
Healthc Q. 2009;12 Spec No Ontario:8-15
pubmed: 19458502
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949

Auteurs

Michael Balas (M)

Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Diana Vasiliu (D)

Health System Intelligence Team, Health System Performance & Support Portfolio, Ontario Health, Toronto, Ontario, Canada.

Gener Austria (G)

Health System Intelligence Team, Health System Performance & Support Portfolio, Ontario Health, Toronto, Ontario, Canada.

Tina Felfeli (T)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada tina.felfeli@mail.utoronto.ca.
The Institute of Health Policy Management and Evaluation (IHPME), University of Toronto, Ontario, Canada, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH